AIG
OREX

American International Group’s Orexigen Therapeutics, Inc. OREX Stock Holding History

American International Group’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-8,725
Closed -$49K – 5157
2016
Q1 		$49K Hold
8,725
– – ﹤0.01% 3895
2015
Q4 		$150K Sell
8,725
-128
-1% -$3.05K ﹤0.01% 3128
2015
Q3 		$187K Buy
8,853
+297
+3% +$10.2K ﹤0.01% 2904
2015
Q2 		$424K Buy
8,556
+851
+11% +$50.9K ﹤0.01% 2324
2015
Q1 		$603K Sell
7,705
-8,349
-52% -$518K ﹤0.01% 2007
2014
Q4 		$973K Sell
16,054
-184
-1% -$9.24K ﹤0.01% 1581
2014
Q3 		$692K Buy
16,238
+211
+1% +$11.3K ﹤0.01% 1856
2014
Q2 		$990K Buy
16,027
+1,737
+12% +$101K ﹤0.01% 1594
2014
Q1 		$929K Buy
14,290
+7,562
+112% +$511K ﹤0.01% 1588
2013
Q4 		$379K Buy
6,728
+384
+6% +$21.6K ﹤0.01% 2237
2013
Q3 		$390K Buy
6,344
+668
+12% +$45.2K ﹤0.01% 2155
2013
Q2 		$332K Buy
+5,676
New +$349K ﹤0.01% 2156

Other funds holding OREX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

American International Group's OREX Position: Q2 2016 in Review

American International Group sold out of Orexigen Therapeutics, Inc. (OREX) in Q2 2016, closing a stake of 8,725 shares — an estimated $49K sold.

American International Group first reported a position in OREX in Q2 2013 and held it in 12 quarters. The position peaked at $990K in Q2 2014. 73 funds tracked by Wall St. Rank hold OREX as of Q2 2016.

  • American International Group reported no remaining Orexigen Therapeutics, Inc. position as of Q2 2016 after selling out during the quarter.
  • American International Group sold 8,725 Orexigen Therapeutics, Inc. shares in Q2 2016, an estimated $49K.
  • American International Group first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 12 quarters.
  • American International Group's Orexigen Therapeutics, Inc. position peaked at $990K in Q2 2014.
  • 73 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2016.

Based on American International Group's 13F filing for Q2 2016, filed 11 Aug 2016.